Dongxing Medical (301290.SZ) released its performance for the first three quarters, with net profit attributable to the parent company of 59.2125 million yuan, a year-on-year increase of 211.30%.

Zhitong Finance APP News, Dongxing Medical (301290.SZ) released its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 330 million yuan, a year-on-year increase of 16.23%. Net profit attributable to shareholders of the listed company was 59.2125 million yuan, a year-on-year increase of 211.30%. Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 38.7647 million yuan, a year-on-year increase of 155.68%.